One-Time Blockbusters to Be Re-Priced at 2.5-Times Gx Price Average; Mevalotin, Takepron among the List

Once high-flying blockbusters will fall victim to a new so-called “G1/G2” re-pricing rule for off-patent brand-name drugs, with Mevalotin (pravastatin) and Takepron (lansoprazole) among the list of medicines to get new NHI prices at 2.5 times the average of their...read more